摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

2-(1,1,2,2-四氟乙氧基)甲苯 | 42145-66-4

中文名称
2-(1,1,2,2-四氟乙氧基)甲苯
中文别名
2-四氟乙氧基甲苯
英文名称
2-(1,1,2,2-tetrafluoroethoxy)toluene
英文别名
1-Methyl-2-(1,1,2,2-tetrafluoroethoxy)benzene
2-(1,1,2,2-四氟乙氧基)甲苯化学式
CAS
42145-66-4
化学式
C9H8F4O
mdl
MFCD00042103
分子量
208.156
InChiKey
OHXFFMAUQJFAAF-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

物化性质

  • 沸点:
    58 °C
  • 密度:
    1.26
  • 闪点:
    59°C
  • 稳定性/保质期:
    常规情况下不会分解,也没有危险反应。

计算性质

  • 辛醇/水分配系数(LogP):
    4.4
  • 重原子数:
    14
  • 可旋转键数:
    3
  • 环数:
    1.0
  • sp3杂化的碳原子比例:
    0.333
  • 拓扑面积:
    9.2
  • 氢给体数:
    0
  • 氢受体数:
    5

安全信息

  • 危险等级:
    3.2
  • 危险品标志:
    Xi
  • 安全说明:
    S26,S36/37/39
  • 危险类别码:
    R36/37/38
  • 海关编码:
    2909309090
  • 包装等级:
    III
  • 危险类别:
    3.2
  • 危险品运输编号:
    1993
  • 储存条件:
    密封、阴凉、干燥保存

SDS

SDS:d22711c9400e807f1740d494979491ac
查看

反应信息

点击查看最新优质反应信息

文献信息

  • [EN] TETRAAZA-CYCLOPENTA[A]INDENYL AND THEIR USE AS POSITIVE ALLOSTERIC MODULATORS<br/>[FR] TÉTRAAZA-CYCLOPENTA[A]INDÉNYLE ET LEUR UTILISATION EN TANT QUE MODULATEURS ALLOSTÉRIQUES POSITIFS
    申请人:MERCK PATENT GMBH
    公开号:WO2013091773A1
    公开(公告)日:2013-06-27
    The present invention provides compounds of Formula (I) as M1 receptor positive allosteric modulators for the treatment of diseases mediated by the muscarinic M1 mediator.
    本发明提供了式(I)化合物,作为M1受体阳性异构调节剂,用于治疗由毒蕈碱M1介质介导的疾病。
  • HETEROCYCLIC CETP INHIBITORS
    申请人:Salvati E. Mark
    公开号:US20070161685A1
    公开(公告)日:2007-07-12
    Compounds of formula Ia and Ib wherein A, B, C and R 1 are described herein.
    式Ia和Ib的化合物 其中A、B、C和R1 如本文所述。
  • BIARYL AMIDE DERIVATIVE OR PHARMACEUTICALLY ACCEPTABLE SALT THEREOF
    申请人:Katayama Seiji
    公开号:US20130116227A1
    公开(公告)日:2013-05-09
    Disclosed is a novel biaryl amide derivative represented by formula (1) and having an affinity for the aldosterone receptor; also disclosed is a pharmaceutically acceptable salt thereof. (In the formula, A is any of the groups represented by formula (a); L is —CONH—, etc.; R 1 is a substitutable aminosulfonyl group, etc.; R 2 is a hydrogen atom, etc.; R 3 is a hydrogen atom, etc.; R 4 is a hydrogen atom, a halogen atom, hydroxy group, a substitutable amino group, a substitutable C 1-6 alkoxy group, a substitutable 4- to 7-membered cyclic amino group, etc.; R 5a , R 5b and R 5c are each independently hydrogen atoms, etc.; R 6 is a halogen atom, a cyano group, etc.; R 7 and R 8 are each independently a hydrogen atom, etc.; and m is an integer such as 0.)
    揭示了一种表示为公式(1)的新型联苯酰胺衍生物,具有与醛固酮受体的亲和力;还揭示了其药用可接受的盐。(在该公式中,A是由公式(a)表示的任何基团之一;L是—CONH—等;R1是可替代的氨基磺酰基等;R2是氢原子等;R3是氢原子等;R4是氢原子、卤原子、羟基、可替代的氨基基团、可替代的C1-6烷氧基、可替代的4-到7-成员环氨基基团等;R5a、R5b和R5c各自独立地是氢原子等;R6是卤原子、氰基等;R7和R8各自独立地是氢原子等;m是整数,例如0。)
  • Imine Compound
    申请人:Saito Shiuji
    公开号:US20080312435A1
    公开(公告)日:2008-12-18
    An imine compound represented by the formula: wherein A represents a heterocyclic group; R 1 , R 2 , an R 3 each represent a hydrogen atom, a halogen atom, a C 1-10 alkyl group optionally substituted with an aryl group(s) substituted with a halogen atom(s), a C 3-10 cycloalkyl group, a C 1-6 haloalkyl group, a C 1-10 alkoxy group, etc.; R 4 represents an optionally substituted C 1-10 alkyl, C 2-6 alkenyl, or aryl group; R 5 represents a hydrogen atom, a C 1-10 alkoxy group, a C 1-6 haloalkyl group, an optionally substituted C 1-10 alkyl or C 2-6 alkenyl group, an optionally substituted aryl or heterocyclic group, etc.; W represents —CO—, —CO—CO—, —CO—NH—, —CS—NH—, or —SO 2 —, or a cannabinoid-receptor agonist comprising said imine compound as an active ingredient. The imine compound of the present invention has a cannabinoid-receptor agonist effect, and is useful as a therapeutic or prophylactic drug for pains and autoimmune diseases.
    一种以以下式表示的亚胺化合物:其中A代表杂环基团;R1、R2和R3分别表示氢原子、卤素原子、C1-10烷基,该烷基可选地取代有芳基,所述芳基取代有卤素原子,C3-10环烷基,C1-6卤代烷基,C1-10烷氧基等;R4表示可选地取代的C1-10烷基,C2-6烯基或芳基;R5表示氢原子,C1-10烷氧基,C1-6卤代烷基,可选地取代的C1-10烷基或C2-6烯基,可选地取代的芳基或杂环基团等;W表示—CO—,—CO—CO—,—CO—NH—,—CS—NH—或—SO2—,或以该亚胺化合物为活性成分的大麻素受体激动剂。本发明的亚胺化合物具有大麻素受体激动剂作用,可用作治疗或预防疼痛和自身免疫性疾病的药物。
  • AZOLYLMETHYLIDENEHYDRAZINE DERIVATIVE AND USE THEREOF
    申请人:Ogura Hironobu
    公开号:US20100190754A1
    公开(公告)日:2010-07-29
    An azolylmethylidenehydrazine derivative represented by the formula (I) wherein Ar is an aryl group optionally having substituent(s) or a heteroaryl group optionally having substituent(s), R 1 and R 2 are the same or different and each is an alkyl group, a cycloalkyl group, an aralkyl group optionally having substituent(s), an aryl group optionally having substituent(s), a heteroarylalkyl group optionally having substituent(s), or R 1 and R 2 are bonded to each other to form a nitrogen-containing heterocyclic group optionally having substituent(s), and X is CH or a nitrogen atom, or a pharmacologically acceptable salt thereof is useful as a medicament, particularly as an antifungal agent, or an anti-inflammatory agent or an antiallergic agent.
    一种以式(I)表示的氮杂环甲基亚唑啉衍生物,其中Ar是一个芳基基团,可选择地具有取代基,或者是一个杂芳基基团,可选择地具有取代基;R1和R2相同或不同,每个都是一个烷基基团、环烷基基团、可选择地具有取代基的芳基烷基基团、可选择地具有取代基的芳基基团、可选择地具有取代基的杂芳基烷基基团,或者R1和R2彼此连接形成一个可选择地具有取代基的含氮杂环基团;X是CH或氮原子;或其药学上可接受的盐,可用作药物,特别是作为抗真菌药物、抗炎药物或抗过敏药物。
查看更多